** At least 3 brokerages raise price targets on The Beauty
Health Co SKIN.O , a day after it outlined a 3-yr plan, aiming
to double sales and triple adj EBITDA by 2025
** D A Davidson hikes PT to $30 from $25, keeps 'buy'
** SKIN's HydraFacial unit is "one of the best businesses we
have seen" and management did a good job detailing global growth
opportunity and drivers of margin expansion - D A Davidson
** Piper Sandler raises SKIN's PT to $23 from $20 and keeps
'overweight' rating, citing confidence in the management's
ability to meet long term targets set and expand margins
** Jefferies hikes PT for SKIN to $22 from $18 while
retaining a 'buy' rating
** "SKIN's first investor day was well-balanced, reinforcing
underappreciated advantages, offering incremental growth
validation," analyst Stephanie Wissink said in a note
** 10 of 11 brokerages rate the stock "buy" or higher, 1
"hold"; their median PT is $21
** Stock rose ~7% on Thursday after the forecast on its
investor day, helping cut YTD losses to ~48%
(Reporting by Mehr Bedi in Bengaluru)
((Mehr.Bedi@thomsonreuters.com;))